2020 Health Trends™ Study

2020 Health Trends Study

Now Available! The Quest Diagnostics Health Trends™ study, published in the journal Population Health Management, compared testing rates and results from across the country before and after the onset of the pandemic.

2020 Health Trends™ Study

Rely on a trusted lab dedicated to responsible testing

With over 50 years of expertise in diagnostic testing, Quest Diagnostics has been providing insights that can lead to more informed decisions. Our drug testing solutions and approach are making a difference in cost and patient care.

Rely on a trusted lab dedicated to responsible testing

Primary care clinician/NP/PA

Helping to protect your patients and your practice

Primary care clinician/NP/PA

Pain specialists

Helping to ensure patient compliance

Pain specialists

Behavioral health & substance use disorder

Timely insights to inform clinical decisions

Behavioral health & substance use disorder

Health systems & community centers

Balancing clinical benefit with cost

Health systems & community centers

See how inconsistent drug test results compare in your state

2019 Health Trends data now available!

An interactive state-by-state overview of patient compliance and inconsistent results

See how inconsistent drug test results compare in your state

Our industry-leading toxicology experts are available to help you with results interpretation.

Give them a call today! 1.877.40.RXTOX (1.877.407.9869)

Our industry-leading toxicology experts are available to help you with results interpretation. Our industry-leading toxicology experts are available to help you with results interpretation. Our industry-leading toxicology experts are available to help you with results interpretation.

State monitors now available

US State Map

Check this out!

Now available, Topics in Drug Testing, a new podcast series from the Quest Diagnostics drug monitoring experts

Click here to listen now or download for later.

OUR BLOG

Helping you stay current in drug monitoring

Full-spectrum CBD may trigger a positive THC result in many patients

Use of so-called “full-spectrum” formulations of cannabidiol (CBD) products can cause users to test positive for THC, the component of marijuana that causes euphoria, according to an open-label study published in JAMA Psychiatry.

Full-spectrum CBD products contain THC, but at levels too low (≤0.30% by weight) to meet federal guidelines…

More stories

Rely on a trusted lab dedicated to responsible testing

With over 50 years of expertise in diagnostic testing, Quest Diagnostics has been providing insights that can lead to more informed decisions. Our drug testing solutions and approach are making a difference in cost and patient care.

Rely on a trusted lab dedicated to responsible testing Rely on a trusted lab dedicated to responsible testing